ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 178,54
0,18%
Dow Jones
44 546,08
-0,37%
DAX
22 513,42
-0,43%
Brent Oil
74,39
0,00%
Bitcoin
97 714,08
0,20%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Zymeworks Inc (ZYME) Cours

Zymeworks Inc

Zymeworks Inc (ZYME)

NASDAQ
15,01
0,39
(2,67%)
Fermé 15 Février 10:00PM
Retardé de 15 minutes
15,55
0,54
(3,60%)
Après les heures de négociation: 1:59AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
15,01
Prix Achat
14,98
Prix Vente
17,00
Volume échangé
239 566
14,56 Fourchette du Jour 15,155
7,97 Plage de 52 semaines 17,70
Cap du marché
1,034B
Clôture Veille
14,62
Ouverture
14,71
Dernière Transaction
50
@
14.99
Dernière heure de transaction
Volume financier
US$ 3 579 170
VWAP
14,9402
Volume moyen (3 m)
448 228
Actions en circulation
68 877 526
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-8,72
Bénéfice par action (BPA)
-1,72
Chiffre d'affairess
76,01M
Bénéfice net
-118,67M

À propos de Zymeworks Inc

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.zymeworks.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Zymeworks Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ZYME. Le dernier cours de clôture d'Zymeworks était de US$14,62. Au cours de la dernière année, les actions de Zymeworks ont été négociées dans une fourchette de prix de US$ 7,97 à US$ 17,70.

Zymeworks compte actuellement 68 877 526 actions en circulation. La capitalisation boursière d'Zymeworks est de US$1,01 milliard. Zymeworks a un ratio cours/bénéfice (ratio PE) de -8.72.

ZYME Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
11 Janvier 2025
ZYME (2,67%)

Form 8-K - Current report
Edgar (US Regulatory)
08 Janvier 2025
ZYME (2,67%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 Janvier 2025
ZYME (2,67%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
07 Janvier 2025
ZYME (2,67%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 Décembre 2024
ZYME (2,67%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
12 Décembre 2024
ZYME (2,67%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.221.4874915483414.7915.5512.821540598214.1139714CS
40.96.3784549964614.1115.5512.821533362314.38999533CS
121.279.2430858806413.7417.0712.4344822814.07563353CS
264.7346.011673151810.2817.79.99554829713.29932011CS
523.6131.666666666711.417.77.9759045711.40647086CS
1568.63135.266457686.3817.76.0156089859.80517701CS
2608.63135.266457686.3817.76.0156089859.80517701CS

ZYME - Frequently Asked Questions (FAQ)

What is the current Zymeworks share price?
The current share price of Zymeworks is US$ 15,01
How many Zymeworks shares are in issue?
Zymeworks has 68 877 526 shares in issue
What is the market cap of Zymeworks?
The market capitalisation of Zymeworks is USD 1,01B
What is the 1 year trading range for Zymeworks share price?
Zymeworks has traded in the range of US$ 7,97 to US$ 17,70 during the past year
What is the PE ratio of Zymeworks?
The price to earnings ratio of Zymeworks is -8,72
What is the cash to sales ratio of Zymeworks?
The cash to sales ratio of Zymeworks is 13,61
What is the reporting currency for Zymeworks?
Zymeworks reports financial results in USD
What is the latest annual turnover for Zymeworks?
The latest annual turnover of Zymeworks is USD 76,01M
What is the latest annual profit for Zymeworks?
The latest annual profit of Zymeworks is USD -118,67M
What is the registered address of Zymeworks?
The registered address for Zymeworks is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Zymeworks website address?
The website address for Zymeworks is www.zymeworks.com
Which industry sector does Zymeworks operate in?
Zymeworks operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
JTAIJet AI Inc
US$ 6,02
(133,33%)
104,48M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
WRDWeRide Inc
US$ 31,4877
(83,39%)
21,07M
INLFINLIF Limited
US$ 16,27
(80,58%)
7,68M
MBRXMoleculin Biotech Inc
US$ 2,1201
(66,94%)
136,66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3,08
(-56,31%)
430,77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3,36
(-52,68%)
5,21k
CSAICloudastructure Inc
US$ 19,0001
(-49,58%)
1,03M
NEXNNexxen International Ltd
US$ 10,30
(-49,16%)
164,82k
BSLKBolt Projects Holdings Inc
US$ 0,6626
(-46,13%)
13,4M
CNSPCNS Pharmaceuticals Inc
US$ 0,1415
(31,26%)
489,28M
MGOLMGO Global Inc
US$ 0,7176
(-15,08%)
417,31M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
INTCIntel Corporation
US$ 23,60
(-2,20%)
230,26M
NVDANVIDIA Corporation
US$ 138,85
(2,63%)
194,99M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ZYME
Zymeworks
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces